ArticleCurrent oncology (Toronto, Ont.)2022

Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.

Massimo Breccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.